Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Analytica Chimica Acta
|
January 28, 2020
Incorporation of quantum carbon dots into a PVP/ZnO hydrogel for use as an effective hexavalent chromium sensing platform
Adam Truskewycz, Sabrina A Beker, Andrew S Ball, et al.
Journal of Environmental Management
|
July 8, 2022
Remediation of groundwater contaminated with dye using carbon dots technology: Ecotoxicological and microbial community responses
Sabrina A Beker, Leadin S Khudur, Christian Krohn, et al.
Digestive Diseases and Sciences
|
May 5, 2000
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group
B Thjodleifsson, J A Beker, C Dekkers, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 1997
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients
J Labenz, J A Beker, C P Dekker, et al.
Alimentary Pharmacology & Therapeutics
|
April 2, 1999
Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study
C P Dekkers, J A Beker, B Thjodleifsson, et al.
Anais Da Academia Brasileira De Ciencias
|
October 11, 2018
Simulation of a surface spill of different diesel/biodiesel mixtures in an ultisol, using natural attenuation and bioaugmentation/biostimulation
Daniel D Meyer, Sabrina A Beker, Karina Heck, et al.
Alimentary Pharmacology & Therapeutics
|
January 20, 1999
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group
C P Dekkers, J A Beker, B Thjodleifsson, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 1998
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group
C P Dekkers, J A Beker, B Thjodleifsson, et al.
European Journal of Gastroenterology & Hepatology
|
May 1, 1995
Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer
J A Beker, G Bianchi Porro, M A Bigard, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2000
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial
N J Talley, M Verlinden, W Snape, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Analytica Chimica Acta
|
January 28, 2020
Incorporation of quantum carbon dots into a PVP/ZnO hydrogel for use as an effective hexavalent chromium sensing platform
Adam Truskewycz, Sabrina A Beker, Andrew S Ball, et al.
Journal of Environmental Management
|
July 8, 2022
Remediation of groundwater contaminated with dye using carbon dots technology: Ecotoxicological and microbial community responses
Sabrina A Beker, Leadin S Khudur, Christian Krohn, et al.
Digestive Diseases and Sciences
|
May 5, 2000
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group
B Thjodleifsson, J A Beker, C Dekkers, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 1997
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients
J Labenz, J A Beker, C P Dekker, et al.
Alimentary Pharmacology & Therapeutics
|
April 2, 1999
Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study
C P Dekkers, J A Beker, B Thjodleifsson, et al.
Anais Da Academia Brasileira De Ciencias
|
October 11, 2018
Simulation of a surface spill of different diesel/biodiesel mixtures in an ultisol, using natural attenuation and bioaugmentation/biostimulation
Daniel D Meyer, Sabrina A Beker, Karina Heck, et al.
Alimentary Pharmacology & Therapeutics
|
January 20, 1999
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group
C P Dekkers, J A Beker, B Thjodleifsson, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 1998
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group
C P Dekkers, J A Beker, B Thjodleifsson, et al.
European Journal of Gastroenterology & Hepatology
|
May 1, 1995
Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer
J A Beker, G Bianchi Porro, M A Bigard, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2000
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial
N J Talley, M Verlinden, W Snape, et al.
Page
of 2